1. Home
  2. NOM vs HBIO Comparison

NOM vs HBIO Comparison

Compare NOM & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Missouri Quality Municipal Income Fund

NOM

Nuveen Missouri Quality Municipal Income Fund

HOLD

Current Price

$10.58

Market Cap

26.7M

Sector

Finance

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$0.59

Market Cap

22.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOM
HBIO
Founded
1993
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
26.7M
22.1M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
NOM
HBIO
Price
$10.58
$0.59
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$2.50
AVG Volume (30 Days)
9.3K
411.9K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
3.39%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$116,176,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.63
$0.28
52 Week High
$12.19
$0.95

Technical Indicators

Market Signals
Indicator
NOM
HBIO
Relative Strength Index (RSI) 36.74 52.75
Support Level $10.30 $0.41
Resistance Level $10.95 $0.64
Average True Range (ATR) 0.28 0.04
MACD -0.06 0.01
Stochastic Oscillator 14.52 64.35

Price Performance

Historical Comparison
NOM
HBIO

About NOM Nuveen Missouri Quality Municipal Income Fund

Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in the United States. The Fund's investment objective is current income exempt from both regular federal income taxes and Missouri personal income taxes, and to enhance portfolio value relative to the Missouri municipal bond market by investing in tax-exempt Missouri municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued. The fund invests in municipal securities as well as floating rate securities, and derivatives such as futures, options, and swap contracts to the necessary extent.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: